Cleared Traditional

K962060 - STREP A OIA MAX
(FDA 510(k) Clearance)

Jul 1997
Decision
421d
Days
Class 1
Risk

K962060 is an FDA 510(k) clearance for the STREP A OIA MAX. This device is classified as a Antisera, All Groups, Streptococcus Spp. (Class I - General Controls, product code GTZ).

Submitted by Biostar, Inc. (Boulder, US). The FDA issued a Cleared decision on July 23, 1997, 421 days after receiving the submission on May 28, 1996.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3740.

Submission Details

510(k) Number K962060 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 1996
Decision Date July 23, 1997
Days to Decision 421 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code GTZ — Antisera, All Groups, Streptococcus Spp.
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3740

Similar Devices — GTZ Antisera, All Groups, Streptococcus Spp.

All 104
BINAX NOW STREPTOCOCCUS PNEUMONIAE TEST
K012521 · Binax, Inc. · Nov 2001
UNI-GOLD STREP A TEST KIT
K011709 · Trinity Biotech, Plc · Nov 2001
MODIFICATION TO BINAX NOW STREPTOCOCCUS PNEUMONIAE URINARY ANTIGEN TEST
K010523 · Binax, Inc. · Mar 2001
BINAX NOWR STREPTOCOCCUS PNEUMONIAE URINARY ANTIGEN TEST (22 TEST KIT),(12 TEST KIT), BINAX NOWR STREPTOCOCCUS PNEUMONI
K991726 · Binax, Inc. · Aug 1999
ABBOTT TESTPACK PLUS STREP A WITH ON BOARD CONTROLS (OBC) II
K971522 · Abbott Laboratories · Mar 1998
STREPTOLEX-STAT
K962296 · Unipath , Ltd. · Dec 1996